Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children
NCT03476135
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class
Conditions
Meningococcal Infections
Interventions
BIOLOGICAL:
MenACYW conjugate vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company